| Name | Title | Contact Details |
|---|
Collafirm is a Monmouth Junction, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Founded in 2009 in France and the USA by Pierre Jerome and Stephane Bette, SpineGuard is an innovative company deploying its proprietary radiation-free real time sensing technology DSG® (Dynamic Surgical Guidance) to secure and streamline the placement of implants in the skeleton. SpineGuard designs, develops and markets medical devices that have been used in over 80,000 surgical procedures worldwide. Sixteen studies published in peer-reviewed scientific journals have demonstrated the multiple benefits DSG® offers to patients, surgeons, surgical staff and hospitals. Building on these solid fundamentals and several strategic partnerships, SpineGuard has expanded its technology platform in a disruptive innovation: the « smart » pedicle screw launched late 2017 and is broadening the scope of applications in dental implantology and surgical robotics. DSG® was co-invented by Maurice Bourlion, Ph.D., Ciaran Bolger, M.D., Ph.D., and Alain Vanquaethem, Biomedical Engineer.
Wetmore Custom Packaging is a Wilmington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Carestream`s products make a difference every day. Carestream Health is a health imaging and information technology solutions company. We provide medical and healthcare IT solutions and X-ray film and digital X-ray products for the non-destructive testing market worldwide. We also provide product, technical, and service support, including remote equipment and software management services. In addition, we own over 600 patents in digital imaging, healthcare IT, film, and imaging chemistry. We became Carestream in 2007 when Onex Corporation purchased Eastman Kodak`s Health Group. Today, we employ approximately 6,000 people who serve a global customer base in over 150 countries. Carestream is headquartered in Rochester, New York, with locations around the world.
Precision Biopsy, LLC was formed in partnership with Allied Minds to develop and commercialize novel technology for the accurate diagnosis of prostate cancer. The company’s diagnostic technology uses advanced spectroscopy imaging techniques in combination with tissue biopsy. For the first time, this unique ability will eliminate random prostate biopsies that are subject to sampling errors and can lead to inaccurate grading and staging of the disease. The scientific founders, professors Priya Werahara and John Daily of the University of Colorado, have long studied the morphology of cancer tissue. Combining their knowledge of advanced spectroscopy techniques has resulted in the ability to image the precise location of cancer in the prostate.